BCG-SSI ® vaccine-associated lymphadenitis: Incidence and management

Conclusions The incidence of BCG-SSI® vaccine associated purulent lymphadenitis varied widely with an increasing trend, followed by the return to the product characteristic limits. Indications for the surgical treatment should not be changed. Extirpation of the purulent BCG adenitis is a safe treatment method and leads to the primary wound healing in the majority of cases.
Source: Medicina - Category: Journals (General) Source Type: research